Yossi Maimon

Plus aucun poste en cours

55 ans

Health Technology

Consumer Services

Profil

Yossi Maimon formerly worked at ColBar LifeScience Ltd., as Chief Financial Officer from 2002 to 2006, Protalix Biotherapeutics, Inc., as CFO, Secretary, Treasurer & Vice President from 2012 to 2019, Protalix Ltd., as Chief Financial Officer, and Old Ayala, Inc., as Chief Financial Officer, Secretary & Treasurer.
Mr. Maimon received his undergraduate degree from City University of New York and Masters Business Admin degree from Tel-Aviv University.

Anciens postes connus de Yossi Maimon

Sociétés	Poste	Fin
ADVAXIS, INC.	Directeur Financier/CFO	19/01/2023
PROTALIX BIOTHERAPEUTICS, INC.	Directeur Financier/CFO	22/07/2019
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Directeur Financier/CFO	01/01/2006
Protalix Ltd.	Directeur Financier/CFO	-

Voir l'expérience en détail de Yossi Maimon

Formation de Yossi Maimon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yossi Maimon

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	6
City University of New York City University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Health Technology
Protalix Biotherapeutics, Inc. Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins	Health Technology
Protalix Ltd.
Old Ayala, Inc. Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies	Health Technology